ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976

Rumors Preceded Broder’s Move

December 22, 1994

In Brief: NCI Award 14 Contracts to Operate The Cancer Information Service

August 13, 1999

In Brief: James Institute Receives $9 Million Gift; NCI’s Fraumeni Wins Public Health Award

November 3, 1995

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995